The apparent contradictions that still make TRAP1 an attractive cancer biomarker will be unveiled after deep analyses of the TRAP1 pathway in individual cancer types and upon careful characterization of unique/selective TRAP1 client proteins in the regulation of cancer cell metabolism and drug resistance. Here, TRAP1 is linked to cancer.